OMCL News Alert Omnicell Inc (OMCL) 35.29 02/14/2015 00:52:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicell Inc (OMCL) 35.29 $OMCL

Omnicell Posts Solid Q4, Positive on 3-Legged Strategies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 8:49AM CST
On Feb 9, 2015, we issued an updated research report on Omnicell Inc. (OMCL).
MDSO: 46.58 (+1.48), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03), ATHN: 134.60 (+4.95)

athenahealth Tops Q4 Earnings & Revenues; '15 View Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:17AM CST
Shares of athenahealth Inc. (ATHN) rallied nearly 2% in after-hours trading on Thursday, following the earnings announcement.
MDSO: 46.58 (+1.48), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03), ATHN: 134.60 (+4.95)

Global Pharmacy Automation Market 2015-2019 with CareFusion, McKesson, Parata Systems & ScriptPro Dominating
M2 - Fri Feb 06, 6:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/35p43b/global_pharmacy) has announced the addition of the "Global Pharmacy Automation Market 2015-2019" report to their offering. Pharmacy automation system is an effective tool to minimize prescription errors and ensure patient safety. It is a system to automate workflow process and eliminate medication errors during packaging and dispensing in the field of medicine and healthcare. Pharmacy automation involves medicine counting, mixing and measuring liquids and powders for compounding, updating customer database, and inventory management. While maintaining accuracy level, the system can bring new business without hiring and training new staff. One key trend in this market is the growing market consolidation. Many vendors in the market are engaging in collaborations and M&A to increase their share in the market. Strategic alliances help vendors gain new capabilities and obtain access to new technologies. According to the report, one of the major drivers of the market is the advances in technology. The latest advances in technology and sophisticated approaches used in various pharmacies and other healthcare facilities have increased the demand for pharmacy automation products. Automation has helped to reduce errors in dispensing medications and has also assisted in improving documentation processes. Further, the report states that one of the major challenges in the market is the intense competition among vendors. A large number of vendors operate in this market. Intense competition among the vendors has resulted in pricing pressure, and, ultimately, a decrease in profitability. The Global Pharmacy Automation market can be segmented into: Automated Medication Dispensing, Automated Storage and Retrieval Systems, Automated Packaging and Labeling, Table-top Tablet Counter, and Automated Compounding Devices. Key Vendors - CareFusion - McKesson - Parata Systems - ScriptPro Other Prominent Vendors - Accu-Chart Plus Healthcare Systems - Aesynt - AmerisourceBergen - ForHealth Technologies - GSE Scale Systems - Health Robotics - Kirby Lester - MedDispence - Omnicell - Pearson Medical Technologies - Rice Lake Weighing Systems - Talyst - Yuyama Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Market Segmentation by End-Users - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/35...l_pharmacy
ABC: 100.34 (+0.51), CFN: 59.81 (+0.01), OMCL: 35.29 (+0.03)

The Best Stock in This Under-Loved Growth Sector
Sophia Lee, The Motley Fool - Motley Fool - Wed Feb 04, 10:04AM CST
If you were to ever to scrutinize the operations of a hospital, you might be surprised to observe how inefficiently hospitals manage their supplies and staff. This is where Omnicell comes in. By providing medical control and patient safety...
ABC: 100.34 (+0.51), MCK: 224.89 (+0.12), CFN: 59.81 (+0.01), OMCL: 35.29 (+0.03)

Omnicell Tops Q4 Earnings, Revenues on 3-Legged Strategy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 9:00AM CST
Omnicell, Inc. (OMCL) reported fourth-quarter adjusted earnings per share of 28 cents .
MDSO: 46.58 (+1.48), QSII: 17.04 (+0.38), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03)

Omnicell (OMCL) Is Today's Strong And Under The Radar Stock
at The Street - Wed Feb 04, 8:45AM CST
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 35.29 (+0.03)

Omnicell's (OMCL) CEO Randall Lipps on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 6:03PM CST

OMCL: 35.29 (+0.03)

Omnicell tops Street 4Q forecasts
Automated Insights - Tue Feb 03, 4:48PM CST
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Tuesday reported fourth-quarter earnings of $9.2 million.
OMCL: 35.29 (+0.03)

Omnicell (OMCL) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 03, 3:25PM CST

OMCL: 35.29 (+0.03)

Omnicell beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 3:15PM CST

OMCL: 35.29 (+0.03)

Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:35PM CST

CALX: 8.65 (-0.03), CHRW: 72.58 (+0.75), WYNN: 159.34 (+4.62), SPA: 22.31 (-0.02), MANH: 51.61 (+0.89), OCLR: 1.55 (+0.09), RSYS: 2.15 (+0.05), NSR: 24.61 (+0.10), CENT: 9.00 (-0.08), CMG: 674.89 (+4.60), AJG: 47.50 (+0.27), IACI: 64.60 (+0.96), VASC: 26.44 (+0.79), SLGN: 56.85 (-0.08), UNM: 34.76 (+0.51), ATW: 33.75 (+0.63), ENTR: 2.92 (unch), AEC: 23.85 (-0.32), AXS: 51.86 (+0.02), MYGN: 34.03 (+0.40), LSCC: 6.10 (+0.02), RNR: 103.80 (-0.64), CBL: 20.52 (-0.14), ATO: 52.52 (-0.65), EW: 134.23 (+1.89), EXP: 81.57 (+2.41), DIS: 104.17 (+0.59), MWA: 9.19 (+0.09), QNST: 6.15 (+0.07), TTWO: 28.40 (+0.96), ULTI: 163.76 (+1.60), PACB: 6.96 (-0.06), FISV: 78.70 (+0.25), GILD: 101.90 (+1.10), JKHY: 65.78 (+0.52), RNG: 16.04 (unch), WNC: 14.01 (+0.38), OMCL: 35.29 (+0.03), AFL: 62.13 (+0.33), HCSG: 33.23 (-0.13), WRB: 50.27 (+0.08), PLNR: 6.63 (-0.07), EQR: 78.75 (-1.11)

Omnicell to Release Fourth Quarter 2014 Earnings Results on February 3
PR Newswire - Tue Jan 27, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Tuesday, February 3, 2015, to discuss the Company's Fourth Quarter 2014 financial results.
OMCL: 35.29 (+0.03)

Omnicell to supply medication automation and analytics solutions at Memorial Sloan Kettering Cancer Center
M2 - Tue Jan 27, 3:28AM CST
Patient automation software company Omnicell (NasdaqGS:OMCL) said on Monday that it will provide its medication automation and analytics solutions to improve workflow and coordination of care between pharmacy and nursing professionals at Memorial Sloan Kettering Cancer Center (MSK).
OMCL: 35.29 (+0.03)

Omnicell to Supply Medication Automation to Major U.S. Cancer Center
PR Newswire - Mon Jan 26, 7:00AM CST
Omnicell, Inc., (NASDAQ: OMCL) today announced that Memorial Sloan Kettering Cancer Center (MSK), the world's oldest and largest private cancer center, has selected Omnicell's medication automation and analytics solutions to improve workflow and coordination of care between pharmacy and nursing professionals.
OMCL: 35.29 (+0.03)

Executives transition at Ommicell
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 3:42PM CST

OMCL: 35.29 (+0.03)

Insider Trading Alert - OMCL, VLGEA And GRPN Traded By Insiders
at The Street - Thu Jan 15, 9:15AM CST
Stocks with insider trader activity include OMCL, VLGEA and GRPN
VLGEA: 28.17 (-0.08), GRPN: 7.97 (+0.51), OMCL: 35.29 (+0.03)

Omnicell and Pocket Nurse Announce Agreement to Provide State-of-the-Art Medication Automation to Nurse Education Organizations
PR Newswire - Wed Jan 14, 9:53AM CST
Omnicell, Inc., (NASDAQ: OMCL), today announced that Pocket Nurse, a leading provider for nursing healthcare education and medical simulation initiatives, has entered into an agreement to bring state-of-the-art medication automation solutions to the nursing education market. Pocket Nurse will develop real-world simulated education curriculums using Omnicell® automated medication dispensing systems for nursing students in healthcare education and medical simulation education programs in the USA & Canada.
OMCL: 35.29 (+0.03)

Long-term Care Software (EHR, eMAR, Payroll Management) Market - Global Forecast to 2019
M2 - Wed Jan 14, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5lqrw9/longterm_care) has announced the addition of the "Long-term Care Software Market by Product, Mode of Delivery & End User - Global Forecast to 2019" report to their offering. The global long-term care software market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $7,561.9 million by 2019 The factors such as rise in aging population that triggers the demand for healthcare IT solutions in LTC facilities, dearth of skilled nursing personnel, and increasing healthcare reforms and government initiatives across the globe are expected to spur the demand for LTC software. Similarly, opportunities offered by remote patient monitoring systems and cloud-based software are expected to boost the demand for LTC software. However, the unwillingness of traditional LTC providers to adopt software and high maintenance costs associated with software are hampering the growth of this market. Moreover, the lack of awareness and inadequate government initiatives in developing countries, resulting in lower adoption of LTC software, poses a challenge to this market. The long-term care software market, by product, is segmented into clinical solutions and non-clinical solutions. The clinical solutions segment is divided into EMR/EHR, e-prescribing, electronic medication administration records, medication management, and clinical decision support systems. The non-clinical solutions segment is further segmented into real-time location systems, remote patient monitoring systems, remote training and supervision systems, payroll management, talent management software and billing, invoicing and scheduling software. The market, by mode of delivery, includes on-premise, web-based, and cloud-based software. The major end users of long-term care software in this report are home health agencies, nursing homes and assisted living facilities, and hospice facilities. The report provides regionwise information on this market as well, split across major regionsNorth America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. By 2019, North America will continue to dominate and drive the long-term care software market, primarily due to the increasing demand for LTC software and the rise in aging population. On the other hand, the Asia-Pacific region is expected to witness significant growth during the forecast period, with the majority of growth primarily driven by changing population demographics and the economic development of regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Long-Term Care Software Market, By Product 8 Long-Term Care Software Market, By Mode Of Delivery 9 Long-Term Care Software Market, By End-User 10 Long-Term Care Software Market, By Geography 11 Competitive Landscape 12 Company Profiles - Allscripts Healthcare Solutions, Inc. - Aod Software (Advanced Answers On Demand, Inc.) - Cerner Corporation - Healthmedx - Kronos Incorporated - Matrix Care - Mckesson Corporation - Omnicare, Inc. - Omnicell, Inc. - Optimus Emr - Pointclickcare - Sigmacare For more information visit http://www.researchandmarkets.com/research/5l...gterm_care
OCR: 76.89 (+0.14), MDRX: 11.80 (+0.04), OMCL: 35.29 (+0.03), CERN: 70.98 (+1.15)

Omnicell Launches Medication Adherence Resource Center
PR Newswire - Mon Jan 12, 12:00PM CST
Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, has launched the Medication Adherence Resource Center, an educational service for the healthcare industry and patients. The resource center is the most comprehensive reference site in the industry and provides, in one place, information on the definition and measurement of medication adherence, salient studies, reviews, reports, and presentations, as well as educational materials and practical tools for healthcare professionals and patients. In addition, the resource center provides frequent updates on medication adherence-related news, research findings, and events.
OMCL: 35.29 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 23

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 56

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 36

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 33

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 43

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Indivior PLC Faces Legal Action Over Securities Violations

Updated Category News Views 87

Indivior PLC Under Legal Scrutiny for Securities Violations Indivior PLC, a prominent player in the pharmaceutical industry, is facing serious legal challenges. A class action lawsuit has been filed against the company, with investors claiming violations of the Securities Exchange Act of 1934. These allegations indicate that Indivior may have misrepresented its financial...

Continue Reading
Spar Nord Bank's Active Share Buyback Program Update

Updated Category News Views 200

Spar Nord Bank's Share Buyback Program Overview Spar Nord Bank has recently made headlines with its announcement of a substantial share buyback program aimed at enhancing shareholder value. The bank's initiative includes a plan to repurchase shares worth up to DKK 500 million, highlighting its commitment to maintaining a robust capital structure and returning value to its...

Continue Reading
Leading Stocks on the Rise: Insights into Market Movements

Updated Category News Views 107

Stock Market Performance Overview The U.S. stock markets experienced a positive trend, highlighted by significant gains on major indices. For instance, the Dow Jones index surged more than 200 points, reflecting a robust investor sentiment in the market. UniFirst Corp: An Acquisition Proposal Shares of UniFirst Corp (NYSE: UNF) saw a remarkable increase during the trading...

Continue Reading
CRF Stock Achieves New Heights Driven by Strong Growth Signals

Updated Category News Views 166

CRF Stock Reaches New Milestones In a brilliant trading session, Cornerstone Total Return Fund Inc (CRF) stock reached a new peak at $8.17, marking its highest point in the past year. This remarkable achievement speaks volumes about the growing investor confidence in the fund's operational strategies and performance amidst changing market landscapes. Within the year, CRF...

Continue Reading
MAG Silver Corp Sees Dramatic Growth in 2024 Financials

Updated Category News Views 185

MAG Silver Corp Reports Notable Growth in 2024 MAG Silver Corp. has made a significant announcement, revealing its financial results for the year ended December 31, 2024. With a focus on growth, the company reported outstanding revenues largely attributed to the Juanicipio Mine, which serves as a cornerstone of its operations. Financial Highlights Key Financial Metrics...

Continue Reading